Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Makio, Kusaoi"'
Autor:
Takumi Saito, Ryo Takatsuji, Goh Murayama, Yu Yamaji, Yukitomo Hagiwara, Yujin Nishioka, Taiga Kuga, Tomoko Miyashita, Makio Kusaoi, Naoto Tamura, Ken Yamaji
Publikováno v:
Immunological Medicine, Vol 47, Iss 4, Pp 264-274 (2024)
Type I interferons (IFN-Is) play a significant role in systemic lupus erythematosus (SLE) pathogenesis. Double-filtration plasmapheresis (DFPP) is a treatment option for SLE; however, its effect on IFN-Is remains unclear. Therefore, we investigated t
Externí odkaz:
https://doaj.org/article/f27e8e2e68fc4fa0ad5b2806c3934536
Autor:
Taiga Kuga, Asako Chiba, Goh Murayama, Kosuke Hosomi, Tomoya Nakagawa, Yoshiyuki Yahagi, Daisuke Noto, Makio Kusaoi, Fuminori Kawano, Ken Yamaji, Naoto Tamura, Sachiko Miyake
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Enhanced interferon α (IFNα) production has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). We previously reported IFNα production by monocytes upon activation of the stimulator of IFN genes (STING) pathway was enhanced
Externí odkaz:
https://doaj.org/article/b93d3836da174a61bef88abcb789f628
Autor:
Yuko Asanuma, Kazuhisa Nozawa, Masakazu Matsushita, Makio Kusaoi, Yoshiyuki Abe, Ken Yamaji, Naoto Tamura
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e19072- (2023)
In complement activation system, although the classical pathway has shown to play a critical role for the pathogenesis of SLE, the role of lectin pathway has remained unknown in the pathogenesis of SLE. As Mannose-binding lectin-associated serine pro
Externí odkaz:
https://doaj.org/article/1e52d0f7c8e647f28030795c84393849
Autor:
Takayuki Sumida, Aya Kawasaki, Hiroshi Hashimoto, Naoyuki Tsuchiya, Isao Matsumoto, Yuya Kondo, Hirofumi Amano, Naoto Tamura, Premita Ari Kusumawati, Yuka Kawamura, Makio Kusaoi, Yasuyoshi Kusanagi, Kenji Itoh, Takashi Fujimoto
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Objective Major histocompatibility complex strongly contributes to susceptibility to systemic lupus erythematosus (SLE). In the European populations, HLA-DRB1*03:01 and DRB1*15:01 are susceptibility alleles, but C4 locus was reported to account for t
Externí odkaz:
https://doaj.org/article/7da6d1da06454ed482299aaf0e3ef8dd
Autor:
Aya Kawasaki, Ken-ei Sada, Premita Ari Kusumawati, Fumio Hirano, Shigeto Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Nobuyuki Ono, Takashi Fujimoto, Makio Kusaoi, Naoto Tamura, Yasuyoshi Kusanagi, Kenji Itoh, Takayuki Sumida, Kunihiro Yamagata, Hiroshi Hashimoto, Hirofumi Makino, Yoshihiro Arimura, Masayoshi Harigai, Naoyuki Tsuchiya
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundDisease relapse remains a major problem in the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In European populations, HLA-DPB1*04:01 is associated with both susceptibility and relapse risk in proteina
Externí odkaz:
https://doaj.org/article/ef4229486aee43e3b9271dc944c7f708
Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
Publikováno v:
Acute and Critical Care, Vol 36, Iss 2, Pp 85-91 (2021)
Endotoxin adsorption therapy by polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) has been used for the treatment of septic shock patients. Endotoxin, an outer membrane component of Gram-negative bacteria, plays an important role in
Externí odkaz:
https://doaj.org/article/26309be3029943f68481455bb8eb4ab4
Autor:
Aya Kawasaki, Natsumi Namba, Ken-ei Sada, Fumio Hirano, Shigeto Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Nobuyuki Ono, Takashi Fujimoto, Makio Kusaoi, Naoto Tamura, Kunihiro Yamagata, Takayuki Sumida, Hiroshi Hashimoto, Shoichi Ozaki, Hirofumi Makino, Yoshihiro Arimura, Masayoshi Harigai, Naoyuki Tsuchiya
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-8 (2020)
Abstract Background Interstitial lung disease (ILD) is a severe complication with poor prognosis in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Prevalence of AAV-associated ILD (AAV-ILD) in Japan is considerably higher th
Externí odkaz:
https://doaj.org/article/837710d4c12748c1a475a279387439a2
Autor:
Ayako Kitada, Takehiro Nakai, Sho Fukui, Ryo Rokutanda, Masato Okada, Makio Kusaoi, Ken Yamaji, Naoto Tamura
Publikováno v:
Lupus. 32:352-362
Objective Tacrolimus is one of the drugs that can be used in pregnancies complicated with systemic lupus erythematosus (SLE), but there are still few reports on its pregnancy outcomes. Although tacrolimus has been reported to cause adverse events, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::519b292a8bec1b9d97c45fb6e5c4ca17
https://doi.org/10.1177/09612033221148334
https://doi.org/10.1177/09612033221148334
Autor:
Aya Kawasaki, Premita Ari Kusumawati, Yuka Kawamura, Yuya Kondo, Makio Kusaoi, Hirofumi Amano, Yasuyoshi Kusanagi, Kenji Itoh, Takashi Fujimoto, Naoto Tamura, Hiroshi Hashimoto, Isao Matsumoto, Takayuki Sumida, Naoyuki Tsuchiya
ObjectiveMajor histocompatibility complex strongly contributes to susceptibility to systemic lupus erythematosus (SLE). In the European populations,HLA-DRB1*03:01andDRB1*15:01are susceptibility alleles, butC4locus was reported to account for the asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4190515f9fd980fd8391d9de2a2e480d
https://doi.org/10.1101/2023.04.05.23288103
https://doi.org/10.1101/2023.04.05.23288103
Autor:
Takanori, Azuma, Kenta, Misaki, Makio, Kusaoi, Yoko, Suzuki, Shinji, Higa, Yoshitaka, Kumon, Tamami, Yoshitama, Taio, Naniwa, Shinsuke, Yamada, Tadashi, Okano, Kimihiko, Takeuchi, Kei, Ikeda, Kenshi, Higami, Masayuki, Inoo, Tetsuji, Sawada, Chonte, Kang, Masatoshi, Hayashi, Yuko, Nagaya, Takafumi, Hagiwara, Eisuke, Shono, Shinkichi, Himeno, Eiichi, Tanaka, Eisuke, Inoue, Yuri, Yoshizawa, Michiaki, Kadode, Hisashi, Yamanaka, Masayoshi, Harigai
Publikováno v:
Modern Rheumatology. 33:271-278
Objectives We performed post-hoc analyses of the ORIGAMI study to investigate whether concomitant methotrexate (MTX) influences the clinical outcomes of abatacept in biologic-naïve patients with rheumatoid arthritis. Methods Enrolled patients (n = 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ae05ea64c2e4e6121bf48304ba3d3d
https://doi.org/10.1093/mr/roac032
https://doi.org/10.1093/mr/roac032